SYNTARA LIMITED — Capital/Financing Update 2021

Sep 20, 2021

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

Announcement Summary

Entity name

PHARMAXIS LTD

Announcement Type

New announcement

Date of this announcement

Tuesday September 21, 2021

The +securities to be quoted are:

+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted

Total number of +securities to be quoted

ASX +security		Number of +securities to
code	Security description	be quoted	Issue date
PXS	ORDINARY FULLY PAID	628,350	21/09/2021

Refer to next page for full details of the announcement

Application for quotation of +securities

1 / 9

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 1 - Entity and announcement details

1.1 Name of entity

PHARMAXIS LTD

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2 Registered number type

ABN

Registration number 75082811630

1.3 ASX issuer code

PXS

1.4 The announcement is

==> picture [8 x 8] intentionally omitted <==

New announcement

1.5 Date of this announcement

21/9/2021

Application for quotation of +securities

2 / 9

Application for quotation of +securities

Part 2 - Type of Issue

==> picture [21 x 22] intentionally omitted <==

2.1 The +securities to be quoted are:

+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted

2.2 The +securities to be quoted are:

==> picture [8 x 8] intentionally omitted <==

Additional +securities in a class that is already quoted on ASX ("existing class")

Application for quotation of +securities

3 / 9

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B

Existing +securities converting into additional +securities in an existing class

FROM (Existing Class) ASX +security code and description PXSAAP : OPTION EXPIRING 06-JUN-2023 EX NIL PRICE

TO (Existing Class)
ASX +security code and description
PXS : ORDINARY FULLY PAID
Please state the number of options	The first date the options were	The last date the options were
that were exercised or other	exercised or other +convertible	exercised or other +convertible
+convertible securities that were	securities were converted	securities were converted
converted		21/9/2021
68,250
Is this all of the options or other +convertible securities on issue of that type		(ie have all of those options now been
exercised or have all of those convertible securities now been converted)?
No
The right of the holder of the options	or other +convertible securities to receive the +underlying securities is being
satisfied by:
An issue of new +securities

The underlying securities being received by the holder are: Intended to be, but are not yet, quoted by ASX

Were the options being exercised or other +convertible securities being converted issued under an +employee incentive scheme? Yes

Are any of the options being exercised or other +convertible securities being converted held by +key management personnel (KMP) or an +associate? No

Issue date

21/9/2021

Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Yes

Application for quotation of +securities

4 / 9

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

Issue details

Number of +securities to be quoted

68,250

Are the +securities being issued for a cash consideration?

==> picture [9 x 8] intentionally omitted <==

No

Please describe the consideration being provided for the +securities

Exercise of zero exercise price options under Pharmaxis Ltd Employee Option Plan

Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted 0.133700

Any other information the entity wishes to provide about the +securities to be quoted

Existing +securities converting into additional +securities in an existing class

FROM (Existing Class) ASX +security code and description

PXSAG : OPTION EXPIRING 28-JUN-2022 EX NIL PRICE

TO (Existing Class) ASX +security code and description

PXS : ORDINARY FULLY PAID

Please state the number of options The first date the options were The last date the options were that were exercised or other exercised or other +convertible exercised or other +convertible +convertible securities that were securities were converted securities were converted converted 21/9/2021 15,000

Is this all of the options or other +convertible securities on issue of that type (ie have all of those options now been exercised or have all of those convertible securities now been converted)? No

The right of the holder of the options or other +convertible securities to receive the +underlying securities is being satisfied by: An issue of new +securities

The underlying securities being received by the holder are: Intended to be, but are not yet, quoted by ASX

Were the options being exercised or other +convertible securities being converted issued under an +employee incentive scheme? Yes

Application for quotation of +securities

5 / 9

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

Are any of the options being exercised or other +convertible securities being converted held by +key management personnel (KMP) or an +associate? No Issue date 21/9/2021 Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Yes Issue details Number of +securities to be quoted 15,000 Are the +securities being issued for a cash consideration? No Please describe the consideration being provided for the +securities Exercise of zero exercise price options under Pharmaxis Ltd Employee Option Plan Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted 0.133700 Any other information the entity wishes to provide about the +securities to be quoted Existing +securities converting into additional +securities in an existing class FROM (Existing Class) ASX +security code and description PXSAAS : PERFORMANCE RIGHTS

Application for quotation of +securities

6 / 9

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

TO (Existing Class) ASX +security code and description

PXS : ORDINARY FULLY PAID

Please state the number of options The first date the options were The last date the options were that were exercised or other exercised or other +convertible exercised or other +convertible +convertible securities that were securities were converted securities were converted converted 21/9/2021 545,100

Is this all of the options or other +convertible securities on issue of that type (ie have all of those options now been exercised or have all of those convertible securities now been converted)? No

The right of the holder of the options or other +convertible securities to receive the +underlying securities is being satisfied by: An issue of new +securities

The underlying securities being received by the holder are:

==> picture [9 x 8] intentionally omitted <==

Intended to be, but are not yet, quoted by ASX

Were the options being exercised or other +convertible securities being converted issued under an +employee incentive scheme?

==> picture [9 x 8] intentionally omitted <==

Yes

Are any of the options being exercised or other +convertible securities being converted held by +key management personnel (KMP) or an +associate?

==> picture [9 x 8] intentionally omitted <==

No

Issue date

21/9/2021

Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Yes

Application for quotation of +securities

7 / 9

Application for quotation of +securities

Issue details

==> picture [21 x 22] intentionally omitted <==

Number of +securities to be quoted

545,100

Are the +securities being issued for a cash consideration?

==> picture [9 x 8] intentionally omitted <==

No

Please describe the consideration being provided for the +securities

Exercise of zero exercise price options under Pharmaxis Ltd Employee Option Plan

Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted

0.133700

Any other information the entity wishes to provide about the +securities to be quoted

Application for quotation of +securities

8 / 9

Application for quotation of +securities

Part 4 - Issued capital following quotation

==> picture [21 x 22] intentionally omitted <==

Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:

(A discrepancy in these figures compared to your own may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.)

4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)

	Total number of
ASX +security code and description	+securities on issue
PXS : ORDINARY FULLY PAID	454,324,339
4.2 Unquoted +securities (total number of each +class of +securities issued	but not quoted on ASX)
	Total number of
ASX +security code and description	+securities on issue
PXSAG : OPTION EXPIRING 28-JUN-2022 EX NIL PRICE	77,000
PXSAAP : OPTION EXPIRING 06-JUN-2023 EX NIL PRICE	66,500
PXSAAS : PERFORMANCE RIGHTS	18,016,350

4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)

Application for quotation of +securities

9 / 9